Elucidating protective immunity against HCV is important for the development of a preventative vaccine. We hypothesize that spontaneous resolution of acute HCV infection offers clue to protective immune responses. and that DAA therapy affects the quality and quantity of HCV-specific T cell responses. To test these hypotheses. https://www.alarecre.com/